Steven E. Waggoner, MD
Chief, Section of Gynecologic Oncology
University Hospitals Case Medical Center
11100 Euclid Avenue
MAC 5034
Cleveland,
OH
USA
44106
Papers:
53
A phase II trial of trebaninib (AMG 386), a selective angiopoietin 1/2 neuralizing peptibody in patients with persistent/recurrent carcinoma of the endometrium: a Gynecologic Oncology Group study
79
Impact of surgical staging and adjuvant therapy on recurrence risk and outcome in stage I non-invasive uterine papillary serous carcinoma
355
Impact of smoking on survival among women treated with and without bevacizumab for advanced cervical cancer (CxCA): an NRG Oncology/Gynecologic Oncology Group study
404
Adjuvant vaginal brachytherapy decreases the risk of vaginal recurrence in patients with stage I non-invasive uterine papillary serous carcinoma
518
Small molecule activators of protein phosphatase 2A for the treatment of endometrial cancer